| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |